published meta-analysis   sensitivity analysis   studies

colchicine in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsGRECCO-19, 2020 0.21 [0.02; 1.97] 0.21[0.02; 1.97]GRECCO-19, 202010%105moderatenot evaluable clinical worseningdetailed resultsGRECCO-19, 2020 0.11 [0.01; 1.08] 0.11[0.01; 1.08]GRECCO-19, 202010%105moderatenot evaluable ventilationdetailed resultsGRECCO-19, 2020 0.17 [0.02; 1.48] 0.17[0.02; 1.48]GRECCO-19, 202010%105moderatenot evaluable0.02.01.0relative treatment effectwww.metaEvidence.org2020-12-01 07:03 +01:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 560 - roots T: 290